WuXi Biologics unveiled plans to invest approximately $60 million and hire roughly 150 employees to establish a state-of-the-art biologics manufacturing facility in Singapore. It will be the tenth global drug substance manufacturing facility of WuXi Biologics. Headquartered in Wuxi city, Jiangsu province, China, WuXi Biologics is a global platform company providing end-to-end solutions for biologics with a mission to accelerate and transform biologics discovery, development and manufacturing ...